Tag: Prescription Drugs
Inhibition of Sclerostin May Increase Cardiovascular Risk
SOST genetic variants linked to lower risk for fracture and osteoporosis but higher risk for MI, major CV AEs
Allopurinol Does Not Affect eGFR in Chronic Kidney Disease
And, serum urate lowering with allopurinol did not affect GFR in T1DM and diabetic kidney disease
Tocilizumab Shows Promise for Treatment of COVID-19
Tocilizumab improves oxygenation and inflammatory biomarkers, may improve survival in severe disease
CDC: 10.7 Percent of U.S. Adults Used Rx Pain Meds in 2015 to 2018
No change found in use of prescription opioids from 2009-2010 to 2017-2018, but increase seen in nonopioid meds
Nephrogenic Systemic Fibrosis Rare With Newer GBCA Exposure
Data scant on exposure to gadolinium-based contrast agents for those with acute kidney injury, risk for CKD
Vitamin D May Cut Colitis Risk for Immune Checkpoint Inhibitors
Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma
Tanezumab Improves Pain, Function in Chronic Low Back Pain
Low back pain intensity at week 16 was improved with tanezumab 10 mg versus placebo
Inhaled Remdesivir May Allow COVID-19 Patients to Be Treated at Home
Currently, the drug has to be given intravenously through daily infusions in the hospital
Court Rules Against Drug Price Disclosures in TV Ads
Judges said HHS exceeded its legal authority by requiring drug price disclosure as part of its stewardship of Medicare, Medicaid
Cardioprotective Therapy Use Lower With Cancer History
Utilization rate of antiplatelet therapies and statins significantly lower for patients with cancer history
